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Abstract
Background: Enhanced Recovery After Surgery (ERAS) programmes aim at an early recovery after surgical trauma
and consequently at a reduced length of hospitalisation. This paper presents the protocol for a study that focuses
on large-scale implementation of the ERAS programme in major gynaecological surgery in the Netherlands. The
trial will evaluate effectiveness and costs of a stepped implementation approach that is characterised by tailoring
the intensity of implementation activities to the needs of organisations and local barriers for change, in comparison
with the generic breakthrough strategy that is usually applied in large-scale improvement projects in the
Netherlands.
Methods: All Dutch hospitals authorised to perform major abdominal surgery in gynaecological oncology patients
are eligible for inclusion in this cluster randomised controlled trial. The hospitals that already fully implemented the
ERAS programme in their local perioperative management or those who predominantly admit gynaecological
surgery patients to an external hospital replacement care facility will be excluded. Cluster randomisation will be
applied at the hospital level and will be stratified based on tertiary status. Hospitals will be randomly assigned to
the stepped implementation strategy or the breakthrough strategy. The control group will receive the traditional
breakthrough strategy with three educational sessions and the use of plan-do-study-act cycles for planning and
executing local improvement activities. The intervention group will receive an innovative stepped strategy
comprising four levels of intensity of support. Implementation starts with generic low-cost activities and may build
up to the highest level of tailored and labour-intensive activities. The decision for a stepwise increase in intensive
support will be based on the success of implementation so far. Both implementation strategies will be completed
within 1 year and evaluated on effect, process, and cost-effectiveness. The primary outcome is length of
postoperative hospital stay. Additional outcome measures are length of recovery, guideline adherence, and mean
implementation costs per patient.
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Discussion: This study takes up the challenge to evaluate an efficient strategy for large-scale implementation.
Comparing effectiveness and costs of two different approaches, this study will help to define a preferred strategy
for nationwide dissemination of best practices.
Trial registration: Dutch Trial Register NTR4058
Keywords: Comparative effectiveness research, Enhanced Recovery After Surgery, Gynaecological oncology, Large-scale
implementation, Perioperative care, Quality improvement collaborative, Randomised controlled trial
Background
Malignant neoplasms are the most important indication
for major surgery in gynaecology in the Netherlands each
year. Approximately 2500 women undergo gynaecological
surgery for ovarian, endometrial, or cervical cancer. In the
last decades, several efforts have been made in trying to
reach optimal perioperative management. In the late 1990s,
Kehlet introduced a renewal process aiming to maintain
normal physiology after surgery [1]. Several evidence-based
elements were combined in a perioperative management
programme, designed to enhance recovery from major sur-
gical trauma [2]. The Enhanced Recovery After Surgery
(ERAS) programme proved to be safe with favourable
effects on recovery and length of stay [3–6]. Although this
programme has been successfully implemented in elective
colonic surgery, a spontaneous diffusion of the ERAS
programme in other elective surgery areas did not occur
[7–11]. Patients undergoing major surgical procedures
remain subjected to unpleasant, unnecessary, and harmful
practices, despite of a large body of evidence supporting
perioperative management improvements [12–14]. As a
result, patients are exposed to an unnecessary pro-
longed hospital stay. Efficient implementation of the
ERAS programme in elective gynaecological surgery
on a large scale is challenging.
In 2010, the ERAS programme was successfully intro-
duced in major gynaecological surgery at the Department
of Gynaecology of Maastricht University Medical Centre
[11]. This resulted in a significant reduction in length of
hospital stay. Nationwide implementation of the ERAS
programme in elective gynaecological surgery did not hap-
pen yet, while this is necessary to achieve high standards
of care and evidence-based practice, with subsequent ben-
efits for the successful execution of clinical trials within
this field [15, 16]. Further, reduced hospitalisation will save
costs and will facilitate the increased patient load by the
imminent centralisation of major gynaecological surgery
in the assigned high-volume centres in the Netherlands.
Finally, a reduced functional decline after surgery will ease
the required early start of postoperative adjuvant chemo-
therapy in patients with ovarian cancer.
In the Netherlands, the quality improvement model
known as the Breakthrough Series [17] is currently adopted
as the preferred method for health care improvement on a
large scale, despite some serious drawbacks [18]. This struc-
tured collaborative learning strategy is designed to help
health care organisations attain best practice in a certain
field. Systematic evaluations have shown that effectiveness
of the breakthrough approach varies and is at the best mod-
erate [19]. Furthermore, breakthrough projects represent
substantial investments of time, effort, and funding and are
assumed to be expensive [20]. A new approach designed to
deliver an optimal effect of implementation efforts at the
lowest possible implementation costs is desirable. Based on
the underlying assumption that organisations may vary
widely in their knowledge, motivation, and capacity to
run a quality improvement programme, as prescribed
in the meta-evaluation of ten such programmes in the
Netherlands [21], a stepped implementation strategy
was designed. This strategy aims to tailor the imple-
mentation efforts to the variety in needs and local
barriers to change. It offers generic low-intensive sup-
port for those who smoothly implement the changes
and a more tailored and intensive approach for those
hospitals having difficulties in making the changes.
This differentiation of the implementation activities to
preparedness for change is described in various theories
on the different phases in a process of change. The Model
for Planning Change of Grol describes ten stages, subdi-
vided into awareness, understanding, acceptance, adop-
tion, and integration of the proposed behaviour [22, 23].
This model was used to select the change interventions
that will be used in the stepped implementation strategy.
Each step leads to a more intensive stage in the process of
change. A tailored approach is intensive and seems less
suitable for large-scale improvement as it requires local
support and elaborative preparatory activities [24, 25].
Evaluation of the process of this implementation effort will
provide insight on why and for whom the developed strat-
egy works and improves the understanding of the stepped
approach. This will help to define a preferred strategy for
nationwide dissemination of best practices.
Objectives
The objective of this study is to compare effectiveness and
costs of a stepped implementation strategy versus the gen-
eric traditional breakthrough methodology for the nation-
wide uptake of the ERAS approach. In addition, the current
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study aims to identify intervention fidelity and context-
ual factors that influence implementation by means of a
process evaluation. The overall aim is to define a pre-
ferred strategy for the large-scale implementation of
evidence-based practice. This paper describes the study
protocol.
Methods
Design
The present study is a non-blinded cluster randomised
controlled trial with two arms comparing an innovative
stepwise implementation approach to the existing gen-
eric breakthrough approach. After approval to participate,
a retrospective baseline measurement of 30 patients will be
performed to assess current perioperative practice. Cluster
randomisation will be applied at the hospital level and will
take place after all retrospective measurements have been
completed. Randomisation will be executed at the central
level by an independent statistician of Maastricht Univer-
sity. The hospitals will be allocated to the intervention
(stepped strategy) or to the control group (breakthrough
strategy) (Fig. 1). After 1 year, the implementation process
will be ended by a final sustainability meeting for both
groups. We assume differences in uptake of innovations
between the high-volume tertiary care hospitals and their
affiliated regional hospitals. Stratified randomisation will be
used to prevent unbalanced intervention groups with
respect to tertiary status or not.
Participants
Hospitals
All Dutch Gynaecology Oncology Group (DGOG) tertiary
referral hospitals and their affiliated regional hospitals
authorised to perform major gynaecological surgery will be
invited to participate in this implementation study. The au-
thorisation is based on the volume norm set by the Dutch
Association of Gynaecologists in 2013. The hospitals that
already fully implemented the ERAS programme in their
local perioperative management are not eligible to partici-
pate. Exclusion will be based on findings of the baseline
audit. To avoid interference in outcome measures, the hos-
pitals that predominantly admit gynaecological surgery pa-
tients to an external hospital replacement care facility after
discharge will be excluded as well. The DGOG, a national
collaborative of professionals involved in the treatment of
women with gynaecological cancers that aims to promote
(inter)national research in gynaecological cancer, supports
the underlying aim to reach nationwide standardisation of
perioperative care consistent with the ERAS programme.
This will support the recruitment of eligible hospitals in
the study. In addition, we expect that cancellation of the
usual 20,000 euro fee for participation to a Dutch Institute
for Healthcare Improvements (CBO)-guided breakthrough
project will be an important incentive towards participa-
tion. For all participating hospitals, costs of implementa-
tion are brought back to costs of joining meetings and
costs of executing local activities.
Cluster randomisation
Breakthrough strategy Stepped strategy
Site visit continued with three 
standard educational sessions 
at 3, 6 and 9 months
Four levels of intensity of 
support depending on progress 
at 0, 3, 6 and 9 months
Sustainability meeting
Hospital assessed for eligibility
Retrospective audit
Implementation 
of ERAS
Exclusion
Control group Intervention group
Fig. 1 Flowchart SINERGY trial
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Professionals
The innovation focuses on a professional level, directed to
individual hospitals and their key target groups. Key target
groups are gynaecologists and anaesthetists involved in gy-
naecological surgery and nurses of the gynaecology depart-
ment. Gynaecological oncologists of the tertiary hospitals
assist in major ovarian surgery in the regional hospitals that
are authorised to perform these procedures. These oncolo-
gists are technical experts assisting in the operating room
and are not involved in pre- and postoperative care. They
are judged to have no influence on the implementation of
the programme in the regional hospitals.
Patients
Women aged over 18 years and scheduled for elective
abdominal surgery for diagnosis and/or treatment of
(suspected) ovarian, endometrial, or cervical cancer will
be included during the 1-year implementation period.
No specific exclusion criteria will be applied.
Control group
Hospitals randomised to the control group will receive the
traditional breakthrough strategy. The breakthrough series
will be performed as usual. The CBO will chair the collab-
orative and recruit an expert panel including subject matter
experts and an implementation expert. All participating
hospitals will be instructed to appoint a multidisciplinary
improvement team to lead the local improvement activities
and will be visited by a CBO consultant and the researcher
of the project to clarify the collaborative processes and
expectations. Three educational sessions will be conducted
with 3 months in between (Fig. 2). At the first learning
session, the kick-off meeting, the expert team presents the
vision of ideal care (the ERAS programme) and shows that
actual care deviates from ideal care. The participants are
taught an approach for organising and carrying out their
improvement activities. This approach is called the Model
for Improvement and identifies four key elements of suc-
cessful process improvement: measurable aims, measures
of improvement, key changes that will result in the desired
performance, and a series of testing cycles, known as plan-
do-study-act (PDSA) cycles [26]. This model enables teams
to test change locally and then reflect, learn, and refine the
changes. At the second and third learning sessions, teams
learn from each other as they report on successes by feed-
ing back their data during the learning sessions, report on
lessons learned, and exchange experiences.
Intervention group
The intervention group will be exposed to the stepped
implementation strategy, which consists of four steps of
implementation activities. This strategy is built on the
assumptions that for some hospitals a generic improvement
approach may be sufficient, while for other hospitals a full-
Digital tool promoting awareness
National level
Interactive educational session
Regional level
Use of opinion leaders  to create a positive intention to change
Local level
Tailored strategy with outreach visit
Intervention group: stepped strategy
Control group: breakthrough strategy
Learning session 3
Learning session 1
Kick-off
Learning session 2Site visit
Su
st
ai
na
bi
lit
y
Time frame of 1 year
Fig. 2 Overview of the stepped and breakthrough implementation strategy. The diagram shows the structure of the breakthrough strategy
(control group) with standard iterative plan-do-study-act (PDSA) cycles and the stepped implementation strategy (intervention group) with four
implementation levels depending on progress. The light blue colour represents the intensity of external support
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blown breakthrough approach or an even more intensive
tailored approach may be required. The four levels of inten-
sity will be offered successively, with 3 months in between
(Fig. 2).
First implementation level
The first implementation step aims at promoting
awareness and comprises a digital toolbox available for
the participating hospitals. The toolbox consists of
background information of the ERAS programme, a
short summary of the programme to use as a reminder
in daily care, and a ready-to-use patient information
sheet to structure patients’ preadmission counselling
and postoperative care. We assume that this toolbox
might pave the way to start implementation for those
clinical leaders who have the skills to guide their
department through this innovation. This assumption
is fed by our experience that in the project ‘implemen-
tation of short stay in breast cancer surgery’ [27] as
well as in the breakthrough project ‘perioperative care’
[28] some hospitals started immediately with treating
patients according to the new programme after the
programme was disseminated.
Second implementation level
The second step is built on support to make change happen
via an interactive learning session, provided by experts in
the field of implementation and experts in the implementa-
tion of the ERAS programme. The overall aim of this
national meeting is to learn about the innovation and to
increase motivation. The perioperative care elements and
the effectiveness and safety of the ERAS programme will be
discussed. Results of baseline measurement will be fed
back, and the gaps between actual practice and optimal
practice will be demonstrated. The subject matters of this
educational meeting are comparable to the kick-off meeting
in the breakthrough series, but the number of participants
is limited to a maximum of three per hospital team to en-
sure interactive participation, promote leadership, and limit
costs.
Third implementation level
The third step is, in contrast to the previous one, a regional
activity and aims at influencing the views regarding the
innovation and creating a positive intention to change. All
locally involved professionals will be invited to participate
in a regional meeting to learn from each other via exchange
of experiences. Professional peers and opinion leaders will
be used to convince them that the programme is valuable,
effective, useful, and feasible.
Fourth implementation level
The fourth level is the most intensive one and acts on the
local level. Activities comprise identification of local barriers
to change and selecting activities to promote the adoption
of the programme. Members of the expert team will con-
duct outreach visits and will guide the local team through
the process of tailoring interventions. Again, audit data will
be used to define to what extent the team deviates from
best practice. Local cultural and environmental issues that
hinder or facilitate the change process will be identified,
and implementation activities will be carefully linked to
these barriers and facilitators to change.
The decision to step up to a higher level of implementa-
tion activities will be based on the success of implementa-
tion. The standards of implementation success include the
following: at least 80 % of patients recovered within 3 days
and at least 60 % of patients going home within 5 days after
surgery. Although we expect the hospitals to include about
25 patients per established evaluation period of 3 months,
we assume that improvements need some time to get in-
corporated in routine practice. The final decision on the
implementation level will be a shared decision with the
hospital, which might have good reasons for clarifying the
lack of success or for preferring to step up to a higher level
of implementation intensity even though the benchmark of
success was reached.
Outcome measures
Process and clinical outcome data will be measured by
predefined indicators of success to study contextual
factors that are critical to the change process. An
effectiveness, economic, and process evaluation will be
conducted throughout the trial.
Effect evaluation
The primary outcome measure is length of hospital stay,
defined as the number of nights that a patient stayed in
hospital after surgery. Secondary outcome measures are
length of recovery and guideline adherence. Recovery is de-
fined as the first day after surgery that the patient fulfilled
all three discharge criteria: tolerance of food, adequate
pain control on oral analgesics, and independency in
activities or daily living. The complete ERAS programme,
as proposed by the ERAS Society® [2], includes over 20
protocol care elements. Index elements were selected as
having a high level of evidence, being readily recordable,
or having a direct influence on recovery. Those elements
are the following: preadmission counselling, no bowel
preparation, carbohydrate load, use of prophylactic an-
tiemetics, removal of nasogastric tube on end of sur-
gery, no peritoneal drainage, start fluids on day 0, start
normal food and mobilisation on day 1, use of epidural
analgesia, use of laxatives, and urinary catheter removal
on day 2. Guideline adherence to the index elements
will be registered for all eligible patients during the
study period.
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Economic evaluation and budget impact
An economic evaluation will be performed. Research has
shown that ERAS leads to cost savings without com-
promising patients’ safety or quality of life [29–31]. As
neither a difference in health outcomes is expected from
implementation of ERAS in gynaecological surgery nor a
difference in costs outside the hospital [32] (i.e. product-
ivity costs), the economic evaluation will basically take
the form of a cost-minimisation analysis and will be per-
formed from a hospital perspective. The effectiveness of
the implementation strategies (length of postoperative
hospital stay) can be expressed as costs. Therefore, for
both strategies, implementation costs will be calculated
and compared with the cost savings due to the reduction
in hospital stay. The strategy which returns the lowest
net costs is considered to be the most cost-effective.
Process evaluation
The quantitative results will be complemented with a
process evaluation. Normally, the outcomes for process
evaluation are only measured in the intervention arm. In
this comparative effectiveness research study, we will
also measure the uptake of the implementation strategy
in the control arm. The evaluation will provide valuable
insights in potential barriers and facilitators that affected
the effectiveness of both implementation strategies.
Process data will be collected in line with a framework
provided by Hulscher et al. to address actual interven-
tion exposure and to describe experiences with the inter-
vention [33]. Implementation fidelity will be monitored
by the registration of guideline adherence to the index
protocol elements during all phases of perioperative
care. The registration of the number and type of profes-
sionals involved and the attendance of the educational
meetings will be measured. The barriers that emerge
during the educational sessions and outreach visits and
the solutions to overcome these barriers will be moni-
tored as well. Besides, all communication between the
expert and local teams will be registered.
Data collection
Before the start of implementation activities, a baseline
audit of process and outcome data will be performed by
reviewing medical charts of the first 30 patients treated in
2012. This period was chosen as the ERAS programme was
not discussed yet in the DGOG. In case of an insufficient
number of patients, the retrospective audit will be com-
pleted with patients operated in 2011. Hereafter, from the
first day of the start till the end of the project 1 year later, a
member of the expert team will monitor process and out-
come data for both the intervention and the control group.
An electronic database supporting good clinical practice
guidelines will be available. Patient characteristics, process
indicators, and outcome measures (proportion of patients
reaching functional recovery within 3 days and proportion
of patients hospitalised for a maximum of 5 days) will be
audited for every 3-month period during the 1-year imple-
mentation period. The timing of the teaching sessions of
the breakthrough project will be synchronous with the tim-
ing of the implementation steps (Fig. 2). Although the
effectiveness of both strategies will be evaluated and
compared every 3 months after every step or teaching
session, the main goal of the study is to compare ef-
fectiveness at the end of the project using all patients
collected during the year. Costs for the two implemen-
tation strategies will be calculated from hours and tar-
iffs for the strategy delivery team (CBO expert, subject
matter experts) as well as all costs for surgeons, anaes-
thetists, and nurses attending implementation-related
activities, including time, travel, and conference ex-
penses. Furthermore, the costs of materials will be
calculated. Additional costs of the audit database will
be calculated as well, as this is an essential part of the
implementation strategies. Standardised forms will be
developed for the measurement of activities, materials,
and expenses associated with implementation [34].
Those forms will be filled in by members of the implemen-
tation team at each site and will provide information for
the economic and process evaluation of the quality
mprovement. Qualitative data regarding the process evalu-
ation will be derived from extensive notes of all contacts
with each hospital and during the educational sessions.
Minutes will be taken by at least two members of the
expert or local implementation team.
Sample size
With the support of the DGOG, we expect to include
the majority of Dutch hospitals and all patients that
will be exposed to major gynaecological surgery dur-
ing the implementation year. Approximately 100 pa-
tients undergo surgery per hospital per year. We do not
expect drop outs among patients as informed consent
procedures and filling in questionnaires by patients is not
needed. The history of adherence to the ERAS protocol in
the Netherlands during the implementation year will be
described, so this study is in principle not about statistics
and sample size calculations. However, it may be still
worthwhile to calculate what statistical differences we will
be able to assess, taking the perspective that this sample
can be seen as an estimate for the future health care or
assuming that some hospitals will not participate as ex-
pected. The stepped implementation strategy is expected
to be superior to the breakthrough strategy in improving
perioperative care processes and reducing the length of
hospital stay. Anticipating a total adherence of 50 % to the
benchmark of length of stay of 5 days or less in the break-
through hospitals versus 70 % adherence in the stepped
implementation hospitals, we would need to randomise
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seven hospitals per arm, each including at least 60 patients
during the whole study period. Sample size computation
was based on an estimated intra-class correlation coeffi-
cient (ICC) of 0.06 in secondary care, a power level of
80 %, and a significance level (α) of 0.05. The intra-class
correlation coefficient used to calculate the sample size
was based on a study of Campbell et al. [35]. Although
this study reported significantly lower ICCs for outcome
variables compared to process variables, we have conser-
vatively computed the sample size using the highest
applicable ICC of 0.06 for secondary care. Using an infla-
tion factor of 11 % to account for unequal cluster size
yields a recruitment target of 67 patients per cluster. It is
possible that no clinically relevant differences (<20 %)
between arms could be found. In such a case, we expect
the stepped implementation programme still to be super-
ior from a financial perspective.
Data analysis
Effect evaluation
Descriptive statistics (proportions, mean, and median) will
be performed for process and outcome data sets. Differ-
ences between groups will be evaluated using independent
sample t-test for numerical variables and chi-square test
for categorical variables. Since patients are nested within
hospitals, implementation effects will be analysed using
linear or logistic mixed-effect model analysis for numer-
ical or binary outcome measures, accounting for a random
hospital effect. Since the four implementation periods can
be considered as different (time) groups, this time variable
will be included as a factor in the regression model.
Besides, subgroup analyses will be performed to describe
trends in implementation over time in more detail. Non-
inferiority comparisons will be presented for outcome
measures using 95 % confidence intervals. Two-sided p
values ≤0.05 will be considered as statistically significant.
Statistical analyses will be performed using SPSS® version
22 software (SPSS, Chicago, Illinois, USA).
Economic evaluation and budget impact
The uncertainty as regards the cost-minimisation re-
sults will be quantified using bootstrapping techniques.
Subgroup and sensitivity analysis will be performed to
test for the robustness of results. An effectiveness ana-
lysis will be performed every 3 months after completing a
learning session. Thus, we will be able to judge to what
level of intensity the activities are worth the effort. Imple-
mentation costs and effectiveness (savings due to reduction
in hospital stay) will be calculated for each period, as well
as cumulative implementation costs and cumulative effect-
iveness. A budget impact analysis will be performed ad-
dressing the financial stream of consequences related to the
uptake and diffusion of the ERAS programme to assess
affordability [36]. The budget impact will depend on both
the costs of both strategies and the effect in terms of hos-
pital stay reduction as well as the current level of uptake of
ERAS.
Process evaluation
Quantitative process data of the implementation study will
be analysed by means of descriptive statistics. Potential bar-
riers and facilitators for successful implementation of the
ERAS programme will be extracted, and open text data will
be categorised in codes. Content analysis will be performed
to analyse the obtained qualitative data of barriers and con-
textual factors of the implementation process.
Ethical approval
The Medical Ethics Committee of the University of
Maastricht confirmed this quality assurance study (METC
13-5-031) was not subjected to the Dutch Clinical Re-
search involving Human Subject Act (WMO). Therefore,
informed consent at the patient level was not necessary.
Privacy of patients’ information is protected by coding
and processing all data anonymously.
Trial status
Trial status at the time of manuscript submission is on-
going. The trial is currently in the last phase of implemen-
tation activities and data collection.
Discussion
This paper presents the protocol of a cluster randomised
controlled study that takes up the challenge to design an
efficient strategy in large-scale implementation. Imple-
mentation of new evidence in practice is complex, and
evaluations have shown a modest to moderate impact of
implementation processes on the achievement of results
[37]. Limited resources increase the need for more effi-
ciency during the implementation process. Therefore, it
is important to explore if there are simpler and cheaper
ways to achieve the same outcomes. To our knowledge,
this is the first study that used an innovative stepped
strategy combining a tailored and successive implemen-
tation approach on the national level. We lack a vali-
dated instrument to measure the stage of change and
the need for more or less intensive implementation
strategies. In the current study, process evaluation is an
important tool to gain insight why and for whom the
developed implementation strategy works. Reviews of
implementation strategies show that interventions are
successful in some settings but fail in others [37, 38].
This stepped strategy allows us to study for whom and why
pure diffusion is effective to change and for whom and why
a surplus of an educational session, the use of opinion
leaders, or a tailored strategy is required. Addressing the
substantial gap between best practices on perioperative care
and current care provided around major gynaecological
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surgery, the study focuses on large-scale implementation of
the Enhanced Recovery After Surgery (ERAS) programme
in the Netherlands. Most Dutch hospitals authorised to
perform major gynaecological surgery will participate
in this study, providing representative results. The
ERAS programme contains several elements to pro-
mote early recovery from major surgical trauma and
consequently reducing length of hospitalisation. Key
index elements were selected to ensure complete and
correct recording of data. Besides, data collection was
carried out by a member of the expert team, limiting
bias in the data collection. ERAS programmes have
showed to be cost-saving [39, 30]. However, resistance
to implement ERAS may arise due to competing prior-
ities and pressure in the workplace. Those issues chal-
lenge the adoption of ERAS in both implementation
groups. Process analysis will help to explore perceived
barriers and facilitators and will contribute to under-
stand and explain study outcomes. This practice-based
study follows an intention to treat analysis to prevent over-
estimation of the implementation effect. One of the limita-
tions of the study is the short time to evaluate the effect of
the different implementations steps. Although a progressive
improvement in process and clinical outcomes might be
expected, the 3-month evaluation periods were chosen to
follow the timing of the breakthrough educational sessions.
Comparing effectiveness and costs of a stepped implemen-
tation approach with tailoring intensity of interventions to
the needs of organisations to the traditionally used break-
through strategy will help to define a preferred strategy for
nationwide dissemination of best practices.
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